Hypnotic effects of low doses of and quazepam in older insomniacs

Journal of Clinical Psychopharmacology

Volumn 17, Issue 5, 1997, Pages 401-406

  Roth, Thomas G ^a   Roehrs, Timothy A ^a   Koshorek, Gail L ^a   Greenblatt, David J ^b   Rosenthal, Leon D ^a  

^a HENRY FORD HOSPITAL   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR STIMULATING AGENT; DEALKYLFLURAZEPAM; PLACEBO; QUAZEPAM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INSOMNIA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP; SLEEP TIME;

AGED; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; POLYSOMNOGRAPHY; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP STAGES; TREATMENT OUTCOME;

EID: 0030850244     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199710000-00009     Document Type: Article

References (21)

1. Ancoli-Israel S. Epidemiology of sleep disorders. In: Roth T, Roehrs T, eds. Clinics in geriatric medicine. Philadelphia: W.B. Saunders, 1989:347-62.
2. Webb WB. Age-related changes in sleep. In: Roth T, Roehrs T, eds. Clinics in geriatric medicine. Philadelphia; W.B. Saunders, 1989:275-87.
3. Mellinger GD, Balter MB, Uhlenhuth E. Insomnia and its treatment. Arch Gen Psychiatry 1985;42:225-32.
4. Salzman C. A primer on geriatric psychopharmacology. Am J Psychiatry 1982;139:67-74.
5. Roehrs T, Zorick F, Wittig R, Roth T. Efficacy of a reduced triazolam dose in elderly insomniacs. Neurobiol Aging 1985;6:189-93.
6. Winsauer HJ, O'Hair DE, Valero R. Quazepam: short-term treatment of insomnia in geriatric patients. Curr Ther Res 1984;35: 228-34.
7. Tietz EI, Roth T, Zorick F, Saab P, Kramer M. The effect of 15 and 20 mg of quazepam (Sch-16134) on the sleep of chronic insomniacs. Curr Ther Res 1979;26:894-9.
8. Kales A. Quazepam: hypnotic efficacy and side effects. Pharmacotherapy 1990;10:1-10.
9. Hilbert JM, Chung M, Radwanski E, Gural R, Symchowicz S, Zampaglione N. Quazepam kinetics in the elderly. Clin Pharmacol Ther 1984;36:566-9.
10. Rechtschaffen A, Kales A. A manual of standardized, techniques and scoring system for sleep stages of human sleep. Los Angeles: Brain Information Service/Brain Research Institute, University of California at Los Angeles, 1968.
11. Bornstein SK. Respiratory monitoring during sleep: polysomnography. In: Guilleminault C, ed. Sleeping and waking disorders: indications and techniques. Menlo Park, CA; Addison-Wesley, 1982:183-212.
12. Coleman RM. Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In: Guilleminault C, ed. Sleeping and waking disorders: indications and techniques. Menlo Park, CA; Addison-Wesley, 1982:265-95.
13. Burstein ES, Friedman H, Greenblatt DJ, Locniskar A. Quantitation of flurazepam and three metabolites by electron capture gas liquid chromatography. J Anal Toxicol 1987;12:122-5.
14. Greenblatt DJ, Divoll M, Harmatz JS, MacLaughlin DS, Shader RI. Kinetics and clinical effects of flurazepam in young and elderly noninsomniacs. Clin Pharmacol Ther 1981;30:475-86.
15. Cotreau MM, Greenblatt DJ. Kinetics, brain uptake, and lipid solubility of quazepam and its metabolites [abstract]. J Clin Pharmacol 1992;32:763.
16. Greenblatt DJ. Benzodiazepine hypnotics: sorting the pharmacokinetic facts. J Clin Psychiatry 1991;52[suppl]:4-10.
17. Chung M, Hilbert JM, Gural RP, Radwanski E, Symchowicz S, Zampaglione N. Multiple-dose quazepam kinetics. Clin Pharmacol Ther 1984;35:52-524.
18. Hilbert JM, Chung M, Maier G, Gural R, Symchowicz S, Zampaglione N. Effect of sleep on quazepam kinetics. Clin Pharmacol Ther 1984;36:99-104.
19. Hilbert JM, Chung M, Maier G, Gural R, Symchowicz S, Zampaglione N. Effect of sleep on quazepam kinetics. Clin Pharmacol Ther 1984;36:99-104.
20. Zampaglione N, Hilbert JM, Ning J, Chung M, Gural R, Symchowicz S. Disposition and metabolic fate of 14C-quazepam in man. Drug Metab Dispos Biol Fate Chem 1985;13:25-9.
21. Roth T, Roehrs T, Vogel GW, Dement WC. Evaluation of hypnotic medications. In: Prien RF, Robinson DS, eds. Clinical evaluation of psychotropic drugs: principles and guidelines. New York: Raven Press, 1994:579-92.